Iliadin

Iliadin

oxymetazoline

Manufacturer:

P&G Health

Distributor:

Zuellig Pharma
Full Prescribing Info
Contents
Oxymetazoline hydrochloride.
Action
Vasoconstriction effect of Oxymetazoline in Iliadin.
Rapid relief of blocked nose improves air flow.
Immediate effect after 25 seconds.
Effect lasts up to 12 hours.
Anti inflammatory (in vitro).
Anti viral effect (in vitro).
Topical vs Oral Nasal Decongestant: (See Table 1.)

Click on icon to see table/diagram/image
Indications/Uses
Acute cold, paranasal sinusitis, syringitis, otitis media.
Dosage/Direction for Use
A Wide Range of Solutions for the Patients' Needs: (See Table 2.)

Click on icon to see table/diagram/image

Duration of Treatment: Unless specifically prescribed by doctor, Iliadin 0.05%, 0.025% and 0.01% should only be used for 7 days. Permanent use of decongestant rhinological agents may attenuate their effect. The abuse of local rhinological agents may cause mucosal athrophy and reactive hyperaemia with rhinitis medicamentosa. Longer use of oxymetazoline may cause damage to the mucosal epithelium with inhibition of ciliary activity. This may possible result in irreversible damage to the mucosa with rhinitis sicca. Long term use and overdosage must be avoided, especially in children. Dosage higher than recommended may only be used under medical supervision.
Contraindications
Rhinitis sicca, hypersensitivity to the active ingredient. In the following cases this drug may only be used after carefully weighing the risk-to-benefit ratio: Patients treated with monoamine oxidase inhibitors (MAO-inhibitors) and other drugs potentially increasing blood pressure; increased intraocular pressure, especially narrow-angle glaucoma; severe cardiovascular disease (e.g. coronary heart disease, hypertension); phaeochromocytoma; metabolic disorders (e.g. hyperthyroidism, diabetes).
Special Precautions
During pregnancy and lactation the recommended dosage should not be exceeded and the preparation should be only used after carefully weighing the risk-to-benefit ratio.
Use In Pregnancy & Lactation
During pregnancy and lactation the recommended dosage should not be exceeded and the preparation should be only used after carefully weighing the risk-to-benefit ratio.
Side Effects
Occasionally, burning or dryness of the nasal mucosa, sneezing. In rare cases - after the effect has worn off – an intense sensation of "blocked" nose (reactive hyperaemia). With topical intranasal use, overdosage leads rarely to occasionally to systemic sympathomimetic effects like palpitations, accelerated pulse (tachycardia) and increase in blood pressure. Restlessness, insomnia, tiredness and headaches have been observed in very rare cases.
Drug Interactions
No interactions with tricyclic antidepressants or monoamine oxidase inhibitors of the tranylcypromine type have been reported in the recommended dosage of Iliadin. Overdosage or swallowing of Iliadin and use of tricyclic antidepressants or MAO - inhibitors simultaneously or immediately prior to administration of Iliadin can lead to an increase blood pressure.
ATC Classification
R01AA05 - oxymetazoline ; Belongs to the class of topical sympathomimetic agents used as nasal decongestants.
Presentation/Packing
Nasal drops 0.01% x 5 mL. 0.025% x 10 mL. 0.05% x 10 mL.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in